JZL195( JZL195 | JZL-195 | JZL 195 )

Catalog No. M17194 CAS No. 1210004-12-8

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

JZL195
Note

Research use only, not for human use.
Brief Description

JZL195 is a selective and efficacious dual FAAH/MAGL inhibitor.
Description

JZL195 is a potent and selective dual inhibitor of FAAH and monacylglycerol lipase (MAGL). JZL195 has greater anti-allodynic efficacy than selective FAAH, or MAGL inhibitors, plus a greater therapeutic window than a cannabinoid receptor agonist. JZL195 may have greater potential in alleviating neuropathic pain, compared to selective FAAH and MAGL inhibitors, or cannabinoid receptor agonists.
In Vitro

JZL195 produces near-complete blockade of FP-Rh labeling of both mouse brain FAAH and MAGL at concentrations as low as 100 nM (IC50 values of 13 and 19 nM, respectively).JZL195 inhibits rat and human FAAH and MAGL enzymes with IC50 values in the range of ≈10-100 nM based on competitive ABPP assays.
In Vivo

JZL195 (20 mg/kg; i.p.) produces an antinociceptive response in the tail immersion assay. Animal Model:Male C57BL/6J miceDosage:20 mg/kg Administration:Intraperitoneal injection Result:Produced a much greater antinociceptive response in the tail immersion assay compared with inhibitors of either FAAH or MAGL alone.
Synonyms

JZL195 | JZL-195 | JZL 195
Pathway

Others
Target

Other Targets
Recptor

FAAH| MAGL
Research Area

Inflammation/Immunology
Indication

——

1. Long JZ, et al. Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20270-5.

Calculator

molnova catalog